Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| VKTX | PRESS-RELEASE | neutral | 1/10 | Viking Therapeutics, Inc announced it will report its Q3 2026 results on October 28, 2026. | Oct 21, 2026 |
| OM | PRESS-RELEASE | neutral | 1/10 | Outset Medical, Inc. announced it will report its Q3 2026 results on November 4, 2026. | Oct 21, 2026 |
| NATR | PRESS-RELEASE | neutral | 1/10 | Nature's Sunshine Products, Inc. announced it will host a conference call on November 4, 2026 to discuss its Q3 2026 res | Oct 21, 2026 |
| NUVB | PRESS-RELEASE | neutral | 1/10 | Nuvation Bio, Inc. announced it will report its Q3 2026 results on November 4, 2026. | Oct 21, 2026 |
| SEER | PRESS-RELEASE | neutral | 1/10 | Seer, Inc. announced it will report its Q3 2026 results on November 10, 2026. | Oct 21, 2026 |
| BBSI | PRESS-RELEASE | neutral | 1/10 | Barrett Business Services Inc announced it will host a conference call on November 4, 2026 to discuss its Q3 2026 result | Oct 21, 2026 |
| ARAY | PRESS-RELEASE | neutral | 1/10 | Accuray Incorporated announced it will report its fiscal Q1 2027 results on November 4, 2026. | Oct 21, 2026 |
| SERA | PRESS-RELEASE | neutral | 1/10 | Sera Prognostics, Inc. announced it will host a conference call on November 4, 2026 to discuss its fiscal Q3 2026 result | Oct 21, 2026 |
| CTKB | PRESS-RELEASE | neutral | 1/10 | Cytek Biosciences, Inc. announced it will report its Q3 2026 results on November 4, 2026. | Oct 21, 2026 |
| PCT | PRESS-RELEASE | neutral | 1/10 | PureCycle Technologies announced it will report its Q3 2026 results on November 4, 2026. | Oct 21, 2026 |
| RELY | PRESS-RELEASE | neutral | 1/10 | Remitly, Inc. announced it will report its Q3 results on November 4, 2026. | Oct 21, 2026 |
| BBT | PRESS-RELEASE | bearish | 5/10 | Beacon Financial reported Q3 2026 GAAP EPS of $0.73, a 6.1% miss vs the $0.78 consensus, with net income declining seque | Oct 21, 2026 |
| ROL | PRESS-RELEASE | bearish | 6/10 | Rollins reported Q3 2026 adjusted EPS of $0.34, a 2.9% YoY decline and a 1.4% miss vs consensus of $0.34 (actual $0.34 v | Oct 21, 2026 |
| SSB | PRESS-RELEASE | bearish | 5/10 | SouthState Bank reported Q3 2026 EPS of $2.30, a 4.2% miss versus the consensus estimate of $2.40, and revenue of $691.1 | Oct 21, 2026 |
| RVMD | PRESS-RELEASE | neutral | 1/10 | Revolution Medicines, Inc. announced it will report its Q3 2026 results on November 4, 2026. | Oct 21, 2026 |
| SGHT | PRESS-RELEASE | neutral | 1/10 | Sight Sciences, Inc. announced it will report its Q3 2026 results on November 4, 2026. | Oct 21, 2026 |
| TCBI | PRESS-RELEASE | bullish | 6/10 | Texas Capital Bancshares reported Q3 2026 EPS of $2.28, a 16.9% beat vs $1.95 consensus, on record net interest income o | Oct 21, 2026 |
| CCNE | PRESS-RELEASE | neutral | 5/10 | CNB Financial reported Q3 2026 EPS of $0.91, a 4.0% beat vs consensus of $0.88, with revenue of $87.8M matching estimate | Oct 21, 2026 |
| GTY | PRESS-RELEASE | bullish | 6/10 | Getty Realty Corp. reported Q3 2026 AFFO of $0.64 per share, beating the $0.61 consensus by 4.9%, and raised full-year 2 | Oct 21, 2026 |
| HBNC | PRESS-RELEASE | bullish | 5/10 | Horizon Bancorp reported Q3 2026 EPS of $0.56, beating the $0.54 consensus by 4.5%, on net income of $28.7M vs $24.9M in | Oct 21, 2026 |
| EVER | PRESS-RELEASE | neutral | 4/10 | EverQuote announced a $50M share repurchase program, signaling management's confidence in cash flow generation and growt | Oct 21, 2026 |
| FRME | PRESS-RELEASE | bullish | 6/10 | First Merchants reported Q3 2026 adjusted EPS of $1.10, beating consensus of $1.04 by 5.8%, with net interest margin exp | Oct 21, 2026 |
| CSX | PRESS-RELEASE | bullish | 7/10 | CSX reported record Q3 2026 revenue of $4.02B (+12% YoY) and diluted EPS of $0.57 (+54% YoY), beating consensus estimate | Oct 21, 2026 |
| GRAL | PRESS-RELEASE | neutral | 1/10 | GRAIL, Inc. announced it will report its Q3 2026 results on November 4, 2026. | Oct 21, 2026 |
| GNTA | PRESS-RELEASE | bearish | 7/10 | Genenta Science received a Nasdaq deficiency notice for failing to maintain a minimum $1.00 bid price for 30 consecutive | Oct 21, 2026 |
| TXN | PRESS-RELEASE | bullish | 6/10 | Texas Instruments reported Q3 2026 revenue of $6.06B (consensus $5.93B) and EPS of $2.62 (consensus $2.43), beating on b | Oct 21, 2026 |
| SEIC | PRESS-RELEASE | mixed | 6/10 | SEI reported Q3 2026 GAAP EPS of $1.38, a 12.7% miss vs consensus of $1.58, though adjusted EPS of $1.64 beat the Street | Oct 21, 2026 |
| META | PRESS-RELEASE | bullish | 7/10 | Meta reported Q3 2026 revenue of $64.60B (+26% YoY) and GAAP diluted EPS of $3.83, which includes a $9.89B litigation ch | Oct 21, 2026 |
| BCRX | PRESS-RELEASE | neutral | 1/10 | BioCryst Pharmaceuticals, Inc. announced it will report its Q3 2026 results on November 4. | Oct 21, 2026 |
| SIRI | PRESS-RELEASE | neutral | 3/10 | Sirius XM declared a regular quarterly cash dividend of $0.27 per share, payable on November 23, 2026, to holders of rec | Oct 21, 2026 |